Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

Resources

OBAT Clinical Tools and Forms

Words Matter
Words to use and avoid when talking about addiction.

Handout - English
Handout - Spanish
Sign the Words Matter Pledge
The Words Matter Pledge (printable PDF)

Clinical Decision-Making Trees

Initiation of Brixadi® Extended-Release Injectable Buprenorphine for Opioid Use Disorder
Guidance for starting a patient on Brixadi® extended-release injectable buprenorphine for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Visit webpage

Initiation of Naltrexone for Alcohol Use Disorder
Guidance for starting a patient on naltrexone for the treatment of alcohol use disorder. This is not meant to replace clinical decision-making.
Download file

Initiation of Naltrexone for Opioid Use Disorder
Guidance for starting a patient on long-acting injectable naltrexone for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Download file

Initiation of Sublocade® Extended-Release Injectable Buprenorphine for Opioid Use Disorder
Guidance for starting a patient on Sublocade® extended-release injectable buprenorphine for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Visit webpage

Initiation of Transmucosal Buprenorphine for Opioid Use Disorder
Guidance for starting a patient on transmucosal buprenorphine for the treatment of opioid use disorder. This is not meant to replace clinical decision-making.
Download file

Pain Management While on Buprenorphine for Opioid Use Disorder
Guidance for managing acute and chronic pain in patients already on buprenorphine for opioid use disorder. This is not meant to replace clinical decision-making.
Download file

Pain Management While on Naltrexone
Guidance for managing acute (anticipated or unanticipated) or chronic pain in patients already on naltrexone. This is not meant to replace clinical decision-making.
Download file

Clinical Tools

Brixadi® Dosing Conversion Tables
Suggested Brixadi® corresponding dosage for patients transitioning from daily sublingual buprenorphine or monthly Sublocade® treatment to monthly or weekly Brixadi® treatment. Tables show the suggested corresponding Brixadi® dose based on current sublingual buprenorphine or Sublocade® dosage.
Visit webpage

Buprenorphine Self Start: Setting Yourself Up for a Successful Initiation
A guide for patients who are starting buprenorphine in the home or community setting.
Download file

Checklist Prior to Buprenorphine-Naloxone Initiation
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 27-28.
Visit webpage

Checklist Prior to Monthly Buprenorphine Injection
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 45-46.
Visit webpage

Checklist Prior to Naltrexone Initiation
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 55-56.
Visit webpage

COWS Scale Opioid Withdrawal Record Induction Form
Download file

DSM-5 Checklist of Diagnostic Criteria: Opioid Use Disorder
Download file

Extended-Release Injectable Buprenorphine Formulation Selection Tool
This tool outlines considerations for each FDA-approved extended-release injectable buprenorphine formulation.
Visit webpage

Novel Naloxone Distribution Strategies
This document outlines potential strategies to increase patient access to nasal naloxone by serving as a guide for administrators, healthcare providers, and non-medical providers attempting to create reimbursable streams for naloxone.
Download file

Patient Medication Guide for Injectable Naltrexone (Vivitrol)
Visit webpage

Perioperative Management
This document gives management guidelines for patients maintained on buprenorphine who are scheduled for surgery or other procedures.
Download file

Transfer Guidelines for Methadone to Buprenorphine or Buprenorphine to Naltrexone Transition
Please reference the 2021 Boston Medical Center OBAT Clinical Guidelines, pages 33-36.
Visit webpage

Consents and Treatment Agreements

Consent for Release of Information (CFR 42)

English
Spanish

Consent for Treatment with Disulfiram

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Injectable Buprenorphine

English
Haitian Creole
Portuguese
Spanish

Consent for Treatment with Naltrexone

English
Haitian Creole
Portuguese
Spanish

Sample OBAT Treatment Agreement

English
Haitian Creole
Portuguese
Spanish

Transmucosal Buprenorphine Consent Form

English
Haitian Creole
Portuguese
Spanish

Sample Visit Documentation

Buprenorphine Initiation Note
Download file

Initial Screening Note Template
Download file

OBAT Nursing Follow-up Note
Example of an OBAT nursing follow-up note used for ongoing assessment of patients engaged in treatment. This template includes documentation of medications for addiction treatment including injectable buprenorphine. This sample visit documentation is meant to serve as a guide.
Download file

OBAT Nursing Intake Note
Example of an OBAT nursing intake note used for comprehensive assessment of new patients. This sample visit documentation is meant to serve as a guide.
Download file

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

The content on this site and the content presented by Grayken Center for Addiction TTA is intended solely to inform and educate healthcare and social service professionals, and shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional. The hospital, the program, and the contributors are not acting as health care providers or professional consultants on behalf of any specific patient and disclaim establishing a provider-patient relationship with any specific patient.


© 2024 Boston Medical Center. All rights reserved. Site by Root802.